Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a patient with primary mucinous testicular adenocarcinoma as a rare case with adjuvant and metastatic sequential treatmentsOzgur Tanriverdi, Mehmet Levent Tarimer, Ceren Deniz Pak, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 25, 2020
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case reportOzgur Tanriverdi, Mehmet L Tarimer, Ceren D Pak, et al.Cancer Investigation|January 13, 2026
Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017-2025)Bilgin Demir, Özgür Tanrıverdi, Taliha Güçlü, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAli Alkan, Arzu Yaşar, Ebru Karcı, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a glottic squamous cell carcinoma with cutaneous metastasisAli Alkan, Deniz Kayış, Serkan Yaşar Çelik, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in TürkiyeOzgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2017
Vaccination in oncology practice and predictorsAli Alkan, Ebru Karcı, Arzu Yaşar, et al.Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 26, 2020
Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)Görkem Türkkan, Ali Alkan, Semra Paydaş, et al.Future Oncology (London, England)|May 10, 2018
Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancerDilsa Mizrak Kaya, Bengi Ozturk, Pinar Kubilay, et al.Pageof 10